by Summary:
George Galloway is tweeting that the Chinese have a safe vaccine for COVID-19, but this is what I found on the Internet. It still has to go through human trails. One of China's COVID-19 vaccine candidates has proven effective in protecting monkeys from the novel coronavirus, according to a report released on May 6 in Science magazine, in the world's first report on animal trial results for COVID-19 vaccine candidates. Global Times Chinese scientists release world’s first animal trials report of COVID-19 vaccine candidate, showing positive results
Topics:
Mike Norman considers the following as important:
This could be interesting, too:
George Galloway is tweeting that the Chinese have a safe vaccine for COVID-19, but this is what I found on the Internet. It still has to go through human trails. George Galloway is tweeting that the Chinese have a safe vaccine for COVID-19, but this is what I found on the Internet. It still has to go through human trails. One of China's COVID-19 vaccine candidates has proven effective in protecting monkeys from the novel coronavirus, according to a report released on May 6 in Science magazine, in the world's first report on animal trial results for COVID-19 vaccine candidates. Global Times Chinese scientists release world’s first animal trials report of COVID-19 vaccine candidate, showing positive results
Topics:
Mike Norman considers the following as important:
This could be interesting, too:
Robert Vienneau writes Austrian Capital Theory And Triple-Switching In The Corn-Tractor Model
Mike Norman writes The Accursed Tariffs — NeilW
Mike Norman writes IRS has agreed to share migrants’ tax information with ICE
Mike Norman writes Trump’s “Liberation Day”: Another PR Gag, or Global Reorientation Turning Point? — Simplicius
One of China's COVID-19 vaccine candidates has proven effective in protecting monkeys from the novel coronavirus, according to a report released on May 6 in Science magazine, in the world's first report on animal trial results for COVID-19 vaccine candidates.
Global Times